FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to a solid medicinal formulation of agent used in prophylaxis and elimination vertigo and a method for its preparing. Agent comprises betahistine as active pharmaceutical component and special additives in the following ratio of components, wt.-%: betahistine hydrochloride, 4-16; microcrystalline cellulose, 25-70; acid stabilizing agent, 1-3; aerosil, 1-10; disintegrating substance, 1.2-5, and lactose, the balance. Invention provides good decomposition capacity and strength of tablet, simplifying preparing the medicinal formulation.
EFFECT: valuable pharmaceutical properties of formulation, improved preparing method.
8 cl, 2 tbl, 1 dwg, 8 ex
Title | Year | Author | Number |
---|---|---|---|
SOLID FORMULATION BETAHISTINE DIHYDROCHLORIDE AND RELATED PRODUCTION PROCEDURE | 2006 |
|
RU2356539C2 |
SOLID DRUG FORM OF IMIPRAMINE WITH IMMEDIATE RELEASE AND METHOD OF OBTAINING THEREOF | 2016 |
|
RU2609198C1 |
ORAL PHARMACEUTICAL COMPOSITION MEMANTIN (OPTIONS) AND METHOD OF PREPARATION (OPTIONS) | 2007 |
|
RU2326660C1 |
ORAL GINDARINE MEDICINE AND PRODUCTION METHOD | 2007 |
|
RU2360675C1 |
IMMEDIATE-RELEASE SOLID DOSAGE FORM OF HYDROXYCHLOROQUINE AND METHOD FOR PRODUCING IT | 2014 |
|
RU2580656C1 |
PHARMACEUTICAL COMBINATION CONTAINING VINPOCETINE AND BETAHISTINE FOR TREATING CEREBRAL CIRCULATORY DEPRESSION | 2008 |
|
RU2386439C2 |
PHARMACEUTICAL COMPOSITION IN FORM OF SOLID PERORAL MEDICINAL FORM, CONTAINING SYGETHINUM (VERSIONS) | 2007 |
|
RU2338523C1 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
PERORAL MEDICINE TILORONE | 2007 |
|
RU2336073C1 |
ANTI-ARRHYTHMIC, ANTI-ANGINAL PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2212236C1 |
Authors
Dates
2007-10-27—Published
2006-05-10—Filed